525 related articles for article (PubMed ID: 25466655)
1. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes.
Mansour A; Mohajeri-Tehrani MR; Qorbani M; Heshmat R; Larijani B; Hosseini S
Nutrition; 2015 Jan; 31(1):119-26. PubMed ID: 25466655
[TBL] [Abstract][Full Text] [Related]
2. l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial.
Houjeghani S; Kheirouri S; Faraji E; Jafarabadi MA
Nutr Res; 2018 Jan; 49():96-106. PubMed ID: 29420997
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
[TBL] [Abstract][Full Text] [Related]
4. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
[TBL] [Abstract][Full Text] [Related]
5. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.
Moloney F; Yeow TP; Mullen A; Nolan JJ; Roche HM
Am J Clin Nutr; 2004 Oct; 80(4):887-95. PubMed ID: 15447895
[TBL] [Abstract][Full Text] [Related]
6. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
[TBL] [Abstract][Full Text] [Related]
7. Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes.
Hermann LS; Ranstam J; Vaaler S; Melander A
Diabetes Obes Metab; 1999 Jul; 1(4):227-32. PubMed ID: 11228758
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
Aghasi M; Koohdani F; Qorbani M; Nasli-Esfahani E; Ghazi-Zahedi S; Khoshamal H; Keshavarz A; Sotoudeh G
J Sci Food Agric; 2019 Jun; 99(8):3933-3940. PubMed ID: 30701554
[TBL] [Abstract][Full Text] [Related]
9. The impact of L-citrulline supplementation on glucose homeostasis, lipid profile, and some inflammatory factors in overweight and obese patients with type 2 diabetes: A double-blind randomized placebo-controlled trial.
Azizi S; Mahdavi R; Mobasseri M; Aliasgharzadeh S; Abbaszadeh F; Ebrahimi-Mameghani M
Phytother Res; 2021 Jun; 35(6):3157-3166. PubMed ID: 33876875
[TBL] [Abstract][Full Text] [Related]
10. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes.
Krebs JD; Bell D; Hall R; Parry-Strong A; Docherty PD; Clarke K; Chase JG
J Am Coll Nutr; 2013; 32(1):11-7. PubMed ID: 24015695
[TBL] [Abstract][Full Text] [Related]
11. Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol.
Lefevre M; Champagne CM; Tulley RT; Rood JC; Most MM
Am J Clin Nutr; 2005 Nov; 82(5):957-63; quiz 1145-6. PubMed ID: 16280425
[TBL] [Abstract][Full Text] [Related]
12. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.
Li D; Zhang Y; Liu Y; Sun R; Xia M
J Nutr; 2015 Apr; 145(4):742-8. PubMed ID: 25833778
[TBL] [Abstract][Full Text] [Related]
13. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.
Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M
Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383
[TBL] [Abstract][Full Text] [Related]
14. Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study.
Navas-Carretero S; Abete I; Zulet MA; Martínez JA
Nutr J; 2011 Jul; 10():74. PubMed ID: 21756320
[TBL] [Abstract][Full Text] [Related]
15. Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials.
Gao C; Liu Y; Gan Y; Bao W; Peng X; Xing Q; Gao H; Lai J; Liu L; Wang Z; Yang Y
Lipids Health Dis; 2020 May; 19(1):87. PubMed ID: 32384902
[TBL] [Abstract][Full Text] [Related]
16. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
17. Effects of low-carbohydrate and low-fat diets: a randomized trial.
Bazzano LA; Hu T; Reynolds K; Yao L; Bunol C; Liu Y; Chen CS; Klag MJ; Whelton PK; He J
Ann Intern Med; 2014 Sep; 161(5):309-18. PubMed ID: 25178568
[TBL] [Abstract][Full Text] [Related]
18. Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.
Sasaki M; Imaeda K; Okayama N; Mizuno T; Kataoka H; Kamiya T; Kubota E; Ogasawara N; Funaki Y; Mizuno M; Iida A; Goto C; Koikeda S; Kasugai K; Joh T
Diabetes Obes Metab; 2012 Apr; 14(4):379-82. PubMed ID: 22098444
[TBL] [Abstract][Full Text] [Related]
19. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ
Menopause; 2007; 14(4):624-9. PubMed ID: 17290158
[TBL] [Abstract][Full Text] [Related]
20. Chromium nicotinate has no effect on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes.
Guimarães MM; Martins Silva Carvalho AC; Silva MS
J Am Coll Nutr; 2013; 32(4):243-50. PubMed ID: 24024769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
